PARSIPPANY, N.J., July 12 /PRNewswire/ — Ferring
Pharmaceuticals Inc., the makers of FIRMAGON® (degarelix for
injection), will sponsor Ed
Randall‘s Bat for the Cure charity, in an effort to
“strike-out prostate cancer” with awareness, education, effective
management and prevention support at the organization’s Minor
League Baseball initiative across the country. FIRMAGON® is a
hormone antagonist therapy for advanced prostate cancer.
“We are honored to support Ed
Randall‘s Bat for the Cure, which has done so much to
educate the public about prostate cancer,” said William Garbarini, Vice President,
Orthopaedics and Urology Business Unit, Ferring Pharmaceuticals
Inc. “As the official charity of Minor League Baseball in
2010, Ed Randall‘s Bat for the
Cure can build on its impressive record, increasing awareness
among thousands of baseball fans. We are thrilled to help them get
the word out.”
Since 2002, Ed Randall‘s Bat
for the Cure has worked to ensure that no man dies needlessly
from prostate cancer due to lack of information about the disease.
Ed Randall‘s Bat for the Cure
educates men on the prevalence of prostate cancer (the most
commonly diagnosed cancer in US men), and emphasizes the importance
of early detection through screening.
From Boise to Jacksonville and many towns and cities
in between, Ed Randall‘s Bat for
the Cure spreads its message during Minor League Baseball
games, distributing educational materials and offering free
prostate cancer screeni
‘/>”/>